Bioresorbable vascular scaffolds (BVS) represent a promising advancement in the treatment of coronary artery disease (CAD), providing temporary mechanical support to the vessel during healing and gradually dissolving thereafter. This technology aims to overcome some limitations of traditional drug-eluting stents (DES), including permanent foreign-body implantation and late-stent thrombosis. This article reviews the design principles, clinical outcomes, challenges, and future prospects of BVS in CAD treatment.